Oxeon is proud to announce that Nick Loporcaro has been named Chief Executive Officer of Landmark Health. Nick will succeed Adam Boehler, the Company’s Founder and former CEO, who has been named Deputy Administrator of CMS and Director of the CMS Innovation Center, effective in April of 2018. With over thirty years of experience, Nick joins Landmark from McKesson where he most recently served as President of McKesson’s U.S. Pharma and Specialty Health businesses which represent $165 billion in revenue. In this role, he was responsible for overseeing business development, sales, distribution, and operations across all markets. Prior to that, he was President of McKesson Canada from 2011 to 2014 and Vice President and General Manager of McKesson from 2003 to 2011.